Kimia Farma Tbk PT
KAEF.JK- Latest Trade
- trading higher1,095IDR
- 5
- 0.46%
- As of Jan 26 2023. Values delayed up to 15 minutes
- Day Range
- 1,090.00 - 1,110.00
- 52-Week Range
- 1,015.00 - 2,310.00
- Previous Close
- 1,090.00
- Open
- 1,090.00
- Volume
- 502,300.00
- 3 Month Average Trading Volume
- 28.37
- Shares Out (Mil)
- 5,554.00
- Market Cap
- 6,053,860.00
- Forward P/E
- -99,999.99
- Dividend Yield
- 1.50
Key Statistics
mean rating - analysts
- P/E Excl. Extra Items (TTM)
- 0.00
- Price To Sales (TTM)
- 0.58
- Price To Book (Quarterly)
- 0.84
- Price To Cash Flow (Per Share TTM)
- 23.10
- Total Debt/Total Equity (Quarterly)
- 123.23
- Long Term Debt/Equity (Quarterly)
- 44.82
- Return On Investment (TTM)
- -1.64
- Return On Equity (TTM)
- -1.01
2021 (millions USD)
About Kimia Farma Tbk PT (KAEF.JK)
Company Information
PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing pharmaceutical products, such as medicines, active pharmaceutical ingredients, traditional medicines, and cosmetics. The Company produces medical devices and chemical materials. The Company is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.
Address
Jalan Veteran No. 9JAKARTA,
10110
Indonesia
Industry
Biotechnology & Drugs
Executive Leadership
- Abdul Kadir
- President Commissioner
- Verdi Budidarmo
- President Director
- Lina Sari
- Finance and Risk Management Director
- Imam Fathorrahman
- Marketing and Commercial Director
- Dharma Syahputra
- General Affair and Human Capital Director
- Jasmine Karsono
- Portfolio and Business Development Director
- Andi Prazos
- Production and Supply Chain Director
- Ganti Winarno Putro
- Corporate Secretary
- Dwi Ary Purnomo
- Commissioner
- Subandi Sardjoko
- Commissioner
- Kamelia Faisal
- Independent Commissioner
- Musthofa Fauzi
- Independent Commissioner
- Rahmat Hidayat Pulungan
- Independent Commissioner
Latest News
- BusinessChina's Silk Road Fund to invest in Indonesian pharma firms
China's Silk Road Fund (SRF) and Indonesia's INA sovereign fund INA invest in two state-owned Indonesian pharmaceuticals companies in a deal worth about 1.86 trillion rupiah ($120 million), a deputy minister said on Sunday.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,929.10 | -- |
| Copper | 792.80 | -- |
| Brent Crude Oil | 87.66 | 0.22% |
| CBOT Soybeans | 1,523.00 | 0.03% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,060.43 | 1.10% |
| Euro STOXX 50 | 4,173.98 | 0.62% |
| FTSE 100 | 7,761.11 | 0.21% |
| Nikkei 225 | 27,373.87 | 0.04% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes